13-42573888-T-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The ENST00000358545.6(TNFSF11):​c.-1+2150T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.465 in 152,036 control chromosomes in the GnomAD database, including 16,685 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.47 ( 16685 hom., cov: 31)

Consequence

TNFSF11
ENST00000358545.6 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.729

Publications

39 publications found
Variant links:
Genes affected
TNFSF11 (HGNC:11926): (TNF superfamily member 11) This gene encodes a member of the tumor necrosis factor (TNF) cytokine family which is a ligand for osteoprotegerin and functions as a key factor for osteoclast differentiation and activation. This protein was shown to be a dentritic cell survival factor and is involved in the regulation of T cell-dependent immune response. T cell activation was reported to induce expression of this gene and lead to an increase of osteoclastogenesis and bone loss. This protein was shown to activate antiapoptotic kinase AKT/PKB through a signaling complex involving SRC kinase and tumor necrosis factor receptor-associated factor (TRAF) 6, which indicated this protein may have a role in the regulation of cell apoptosis. Targeted disruption of the related gene in mice led to severe osteopetrosis and a lack of osteoclasts. The deficient mice exhibited defects in early differentiation of T and B lymphocytes, and failed to form lobulo-alveolar mammary structures during pregnancy. Two alternatively spliced transcript variants have been found. [provided by RefSeq, Jul 2008]
TNFSF11 Gene-Disease associations (from GenCC):
  • autosomal recessive osteopetrosis 2
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • autosomal recessive osteopetrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 13-42573888-T-C is Benign according to our data. Variant chr13-42573888-T-C is described in ClinVar as Benign. ClinVar VariationId is 1297311.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.504 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNFSF11NM_033012.4 linkc.-1+2150T>C intron_variant Intron 3 of 6 NP_143026.1
TNFSF11XM_047430707.1 linkc.-1+2150T>C intron_variant Intron 1 of 4 XP_047286663.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNFSF11ENST00000358545.6 linkc.-1+2150T>C intron_variant Intron 3 of 6 1 ENSP00000351347.2

Frequencies

GnomAD3 genomes
AF:
0.465
AC:
70685
AN:
151918
Hom.:
16659
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.510
Gnomad AMI
AF:
0.473
Gnomad AMR
AF:
0.407
Gnomad ASJ
AF:
0.322
Gnomad EAS
AF:
0.472
Gnomad SAS
AF:
0.394
Gnomad FIN
AF:
0.520
Gnomad MID
AF:
0.351
Gnomad NFE
AF:
0.456
Gnomad OTH
AF:
0.447
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.465
AC:
70752
AN:
152036
Hom.:
16685
Cov.:
31
AF XY:
0.468
AC XY:
34784
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.510
AC:
21145
AN:
41444
American (AMR)
AF:
0.407
AC:
6218
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.322
AC:
1117
AN:
3470
East Asian (EAS)
AF:
0.473
AC:
2446
AN:
5174
South Asian (SAS)
AF:
0.393
AC:
1890
AN:
4814
European-Finnish (FIN)
AF:
0.520
AC:
5510
AN:
10586
Middle Eastern (MID)
AF:
0.364
AC:
107
AN:
294
European-Non Finnish (NFE)
AF:
0.456
AC:
30950
AN:
67946
Other (OTH)
AF:
0.444
AC:
938
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1915
3829
5744
7658
9573
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
648
1296
1944
2592
3240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.451
Hom.:
22708
Bravo
AF:
0.459
Asia WGS
AF:
0.427
AC:
1485
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 19131500, 18502820)

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
8.0
DANN
Benign
0.49
PhyloP100
0.73
PromoterAI
0.029
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9525641; hg19: chr13-43148024; API